Literature DB >> 10371275

Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans.

R E Tager1, M Tikly.   

Abstract

A retrospective study of systemic sclerosis (SSc) in Blacks attending a tertiary hospital on the Witwatersrand, South Africa, was undertaken. The female:male ratio of the 63 patients was 4.6:1 and the mean age of onset of SSc was 36.1 yr. Four of the 11 males were ex-goldminers and nine females resided close to goldmines. Forty-one patients had diffuse cutaneous SSc (dcSSc), 18 had limited cutaneous SSc (lcSSc) and four were unclassified. Overall, 56% had pulmonary fibrosis, 37% had myositis and 98% were antinuclear antibody (ANA) positive, with a notable absence of anti-centromere antibodies. Subset comparisons showed myositis and a reduced forced vital capacity to be significantly more common with dcSSc than lcSSc. The only significant sex differences were that arthralgia/arthritis was more common in women, while calcinosis occurred more frequently in men. Seven of the eight known deaths occurred in patients with dcSSc. These findings, particularly the age of disease onset, predominance of the dcSSc subset, inflammatory features of myositis and a raised erythrocyte sedimentation rate, and absence of anti-centromere antibodies, are similar to those reported previously in African-Americans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10371275     DOI: 10.1093/rheumatology/38.5.397

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  12 in total

1.  Interstitial lung disease in South Africans with systemic sclerosis.

Authors:  Philippa Ashmore; Mohammed Tikly; Michelle Wong; Claudia Ickinger
Journal:  Rheumatol Int       Date:  2017-11-28       Impact factor: 2.631

2.  Connective tissue disease in a Malawian man.

Authors:  Allain Theresa; Banda Ndaziona; Van Gaalen Floris
Journal:  Malawi Med J       Date:  2010-03       Impact factor: 0.875

3.  New centromere autoantigens identified in systemic sclerosis using centromere protein microarrays.

Authors:  Guang Song; Chaojun Hu; Heng Zhu; Li Wang; Fengchun Zhang; Yongzhe Li; Lin Wu
Journal:  J Rheumatol       Date:  2013-02-15       Impact factor: 4.666

4.  Mucocutaneous and demographic features of systemic sclerosis: a profile of 46 patients from eastern India.

Authors:  Sudip Kumar Ghosh; Debabrata Bandyopadhyay; Indranil Saha; Jayanta Kumar Barua
Journal:  Indian J Dermatol       Date:  2012-05       Impact factor: 1.494

5.  Lipid peroxidation and trace elements in systemic sclerosis.

Authors:  Mohammed Tikly; Kalavati Channa; Penny Theodorou; Mairam Gulumian
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

6.  Clinical and laboratory features of African-Brazilian patients with systemic sclerosis.

Authors:  Cristiane Mendes; Vilma S T Viana; Sandra G Pasoto; Elaine P Leon; Eloisa Bonfa; Percival D Sampaio-Barros
Journal:  Clin Rheumatol       Date:  2019-05-07       Impact factor: 2.980

7.  Scleroderma (systemic sclerosis) among Nigerians.

Authors:  O O Adelowo; S Oguntona
Journal:  Clin Rheumatol       Date:  2009-05-13       Impact factor: 2.980

Review 8.  Muscle involvement in systemic sclerosis: points to consider in clinical trials.

Authors:  Ulrich A Walker; Philip J Clements; Yannick Allanore; Oliver Distler; Chester V Oddis; Dinesh Khanna; Daniel E Furst
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

Review 9.  Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations.

Authors:  John D Reveille
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686

10.  Prevalence of anti-histone antibodies, their clinical significance and correlation with other autoantibodies in a cohort of Italian scleroderma patients.

Authors:  Gabriella Morozzi; Francesca Bellisai; Irene Fineschi; Francesca Scaccia; Gabriella Pucci; Antonella Simpatico; Marilina Tampoia; Alessandra Chialà; Giovanni Lapadula; Mauro Galeazzi
Journal:  Auto Immun Highlights       Date:  2011-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.